YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Potential Diagnostic and Prognostic Significance of Plasma Prolidase Activity in Gastric Cancer

dc.authorid Yilmaz, Ozkan/0000-0001-7320-0722
dc.authorscopusid 36774252500
dc.authorscopusid 24335444000
dc.authorscopusid 56692252500
dc.authorscopusid 55998916900
dc.authorscopusid 56259656000
dc.contributor.author Celik, Sebahattin
dc.contributor.author Kiziltan, Remzi
dc.contributor.author Yilmaz, Eyup M.
dc.contributor.author Yilmaz, Ozkan
dc.contributor.author Demir, Halit
dc.date.accessioned 2025-05-10T17:28:03Z
dc.date.available 2025-05-10T17:28:03Z
dc.date.issued 2017
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Celik, Sebahattin; Kiziltan, Remzi; Yilmaz, Ozkan] Yuzuncu Yil Univ, Dept Gen Surg, Fac Med, Van, Turkey; [Yilmaz, Eyup M.] Van Training & Educ Hosp, Dept Surg, Van, Turkey; [Demir, Halit] Yuzuncu Yil Univ, Dept Chem, Fac Sci & Art, Van, Turkey en_US
dc.description Yilmaz, Ozkan/0000-0001-7320-0722 en_US
dc.description.abstract Aim: Plasma prolidase activities (PPAs) in cases of gastric cancer. Methodology/results: This study was based on a prospective design. 60 patients with gastric cancer (operable cases: 48; inoperable: 12) and 60 healthy controls were included in the study. Prolidase activity was analyzed. The mean PPA levels in the operable, inoperable and control groups were 45.60 +/- 4.20, 54.35 +/- 4. 9 and 10.92 +/- 0.79 U/l, respectively (p < 0.001). PPA decreased significantly after tumor resection. PPA level was significant in differentiating operable cases from inoperable (sensitivity: 91.7%; specificity: 85.2%). Discussion/conclusion: PPA was significantly higher in patients with inoperable gastric cancer than in operable cases and the control group. A strong correlation was found between tumor volume and PPA. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.2217/bmm-2016-0367
dc.identifier.endpage 327 en_US
dc.identifier.issn 1752-0363
dc.identifier.issn 1752-0371
dc.identifier.issue 4 en_US
dc.identifier.pmid 28150509
dc.identifier.scopus 2-s2.0-85016758520
dc.identifier.scopusquality Q3
dc.identifier.startpage 319 en_US
dc.identifier.uri https://doi.org/10.2217/bmm-2016-0367
dc.identifier.uri https://hdl.handle.net/20.500.14720/11924
dc.identifier.volume 11 en_US
dc.identifier.wos WOS:000401945400003
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Future Medicine Ltd en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Enzymes en_US
dc.subject Gastric Cancer en_US
dc.subject Prognostic Factors en_US
dc.subject Prolidase Activity en_US
dc.subject Tumor Markers en_US
dc.title Potential Diagnostic and Prognostic Significance of Plasma Prolidase Activity in Gastric Cancer en_US
dc.type Article en_US

Files